Does CPAP Reduce Atrial Fibrillation Recurrence After Ablation?
In people with obstructive sleep apnea who had a catheter ablation for atrial fibrillation, using CPAP was associated with 63% lower odds of the arrhythmia coming back (odds ratio 0.37, 95% confidence interval 0.23 to 0.58). That comes from a 2025 systematic review and meta-analysis pooling 11 studies and 1,536 patients. Ten of those 11 studies were observational, and the one randomized trial in the pool found no difference between groups.
Dr. Kumar’s Take
The direction here is consistent and the size of the association is large. What keeps me from treating it as settled is the composition of the evidence: 10 observational studies and 1 randomized trial, and the randomized trial is the one that came up empty. That pattern is familiar in adherence research. People who use CPAP faithfully tend to differ from people who do not in ways that also affect arrhythmia risk, and no statistical adjustment fully removes that.
What makes the finding more interesting than a simple adherence artifact is where the effect got stronger. Restricting to studies with follow-up of 18 months or longer moved the odds ratio to 0.28, which is 72% lower odds. Restricting to studies where at least half the patients had persistent atrial fibrillation gave 0.31, or 69% lower odds. A pure healthy-adherer effect would not usually sharpen with longer follow-up and harder disease.
For a patient of mine with atrial fibrillation and untreated sleep apnea heading toward an ablation, I bring up the sleep apnea before the procedure is scheduled. I present it as something worth doing that is probably helping, not as a proven guarantee against recurrence.
Key Findings
The pooled analysis included 1 randomized controlled trial and 10 observational studies, covering 1,536 patients with obstructive sleep apnea who underwent catheter ablation for atrial fibrillation. Fifty-three percent of them used CPAP.
Atrial fibrillation recurrence was significantly lower in the CPAP group (odds ratio 0.37, 95% confidence interval 0.23 to 0.58, p < 0.01), which is 63% lower odds of recurrence.
Two subgroup analyses pointed the same way. In studies with mean follow-up of 18 months or longer, the odds ratio was 0.28 (95% CI 0.18 to 0.46, p < 0.01), or 72% lower odds. In studies where 50% or more of patients had persistent atrial fibrillation rather than paroxysmal, the odds ratio was 0.31 (95% CI 0.16 to 0.61, p < 0.01), or 69% lower odds.
Mean follow-up across the included studies ranged from 3 to 42 months.
Brief Summary
This meta-analysis asked whether CPAP changes the odds that atrial fibrillation returns after catheter ablation in patients who also have obstructive sleep apnea. The investigators searched PubMed, EMBASE, and Cochrane for randomized controlled trials and observational studies comparing CPAP use against no CPAP use in that population. Eleven studies with 1,536 patients met the criteria. The outcome was recurrence of atrial fibrillation after ablation.
Study Design
This was a systematic review and meta-analysis. Three databases were searched: PubMed, EMBASE, and Cochrane. Both randomized controlled trials and observational studies were eligible, provided they compared CPAP against no CPAP for sleep apnea treatment and reported atrial fibrillation recurrence following catheter ablation. One randomized trial and 10 observational studies qualified, totaling 1,536 patients. Heterogeneity was assessed with the i2 statistic. Prespecified subgroups looked at longer follow-up and at studies with a higher proportion of persistent atrial fibrillation.
Results You Can Use
Among patients with obstructive sleep apnea who had a catheter ablation, CPAP use was associated with 63% lower odds of atrial fibrillation recurrence compared with not using CPAP (odds ratio 0.37, 95% confidence interval 0.23 to 0.58).
The association did not fade with time. It was larger, not smaller, in the studies that followed patients for 18 months or more.
The one randomized controlled trial in the pool showed no difference between groups. The authors say this directly in their conclusion and ask readers to interpret the pooled result with caution.
If you have both conditions and an ablation is on the table, treating the sleep apnea belongs in the same conversation as the procedure, not in a separate one.
Why This Matters For Health And Performance
Obstructive sleep apnea is a known predictor of both the onset and the recurrence of atrial fibrillation. Ablation is an expensive, invasive procedure with a meaningful recurrence rate, so anything that improves the odds of a durable result is worth attention.
The practical implication is that sleep apnea screening and treatment deserve a place in the workup of patients with atrial fibrillation, particularly patients heading for an ablation.
How to Apply These Findings in Daily Life
- Screen for sleep apnea: If you have atrial fibrillation, ask your cardiologist about being evaluated for obstructive sleep apnea
- Use the CPAP you were prescribed: This analysis compared CPAP users with nonusers, and the users were the ones with less recurrence
- Raise it before the ablation: The population studied here was patients who underwent catheter ablation, so bring sleep apnea treatment up while the procedure is still being planned
- Stay with it: The association was strongest in the studies that followed patients 18 months or longer
- Coordinate care: Make sure your cardiologist and your sleep specialist are working from the same plan
- Monitor heart rhythm: Track any episodes you notice and bring the pattern to your care team
Limitations To Keep In Mind
Ten of the 11 pooled studies were observational, so patients were not randomly assigned to use CPAP. Comparisons of this kind cannot rule out that CPAP users differ from nonusers in other ways that affect arrhythmia risk. The single randomized controlled trial in the analysis found no difference between groups, and the authors flag that explicitly as a reason for caution. The analysis evaluated CPAP specifically, so it does not speak to other treatments for obstructive sleep apnea. Follow-up varied widely across studies, from 3 months to 42 months. The population was limited to patients who underwent catheter ablation, so it does not address people managed medically without a procedure.
Related Studies And Internal Links
- CPAP Reduces Blood Pressure in Resistant Hypertension
- CPAP vs Oxygen for Sleep Apnea: Cardiovascular Outcomes
- Upper Airway Stimulation for Sleep Apnea Treatment
- Sleep Apnea Screening: STOP-Bang Questionnaire Performance
- How to Sleep Better: Science Daily Playbook
FAQs
Is sleep apnea linked to atrial fibrillation?
Yes. Obstructive sleep apnea is a known predictor of both the onset and the recurrence of atrial fibrillation, which is why this analysis looked at whether treating it changes recurrence after ablation.
Will treating my sleep apnea cure my atrial fibrillation?
This analysis found lower odds of recurrence among CPAP users, not an absence of recurrence. Most of the underlying data is observational, and the one randomized trial in the pool showed no difference between groups. It supports CPAP as part of atrial fibrillation care rather than as a replacement for it.
Does CPAP still help if I have already had an ablation?
Everyone in this analysis had undergone catheter ablation. That is the population where the 63% lower odds of recurrence was observed.
How long do I need to stay on CPAP to see this?
The studies with mean follow-up of 18 months or longer showed the largest association, at 72% lower odds of recurrence. Shorter studies showed a smaller effect.
Conclusion
In this meta-analysis of 1 randomized trial and 10 observational studies covering 1,536 patients, CPAP use in people with obstructive sleep apnea who underwent catheter ablation was associated with 63% lower odds of atrial fibrillation recurrence (odds ratio 0.37, 95% confidence interval 0.23 to 0.58). The association was stronger in studies with longer follow-up and in studies with more persistent atrial fibrillation. Because 10 of the 11 studies were observational and the single randomized trial found no difference, this is supporting evidence for treating sleep apnea as part of atrial fibrillation management rather than proof that CPAP prevents recurrence.
